In a remarkable display of bench to bedside science, a therapeutic developed by U-M’s Michelle Hastings, Ph.D. is now being used to treat twin girls with a rare form of juvenile Batten disease.
In a remarkable display of bench to bedside science, a therapeutic developed by U-M’s Michelle Hastings, Ph.D. is now being used to treat twin girls with a rare form of juvenile Batten disease.